25 related articles for article (PubMed ID: 17471022)
1. Adenovirus-mediated interleukin-12 gene transfer combined with cytosine deaminase followed by 5-fluorocytosine treatment exerts potent antitumor activity in Renca tumor-bearing mice.
Hwang KS; Cho WK; Yoo J; Yun HJ; Kim S; Im DS
BMC Cancer; 2005 May; 5():51. PubMed ID: 15910693
[TBL] [Abstract][Full Text] [Related]
2. Circumvention of 5-fluorouracil resistance in human stomach cancer cells by uracil phosphoribosyltransferase gene transduction.
Inaba M; Sawada H; Sadata A; Hamada H
Jpn J Cancer Res; 1999 Mar; 90(3):349-54. PubMed ID: 10359051
[TBL] [Abstract][Full Text] [Related]
3. The nature of the modification at position 37 of tRNAPhe correlates with acquired taxol resistance.
Pan Y; Yan TM; Wang JR; Jiang ZH
Nucleic Acids Res; 2021 Jan; 49(1):38-52. PubMed ID: 33290562
[TBL] [Abstract][Full Text] [Related]
4. Nanoparticle-delivered suicide gene therapy effectively reduces ovarian tumor burden in mice.
Huang YH; Zugates GT; Peng W; Holtz D; Dunton C; Green JJ; Hossain N; Chernick MR; Padera RF; Langer R; Anderson DG; Sawicki JA
Cancer Res; 2009 Aug; 69(15):6184-91. PubMed ID: 19643734
[TBL] [Abstract][Full Text] [Related]
5. Drug resistance‑related gene targets and molecular mechanisms in the A2780/Taxol‑resistant epithelial ovarian cancer cell line.
Yang R; Zhang H; Chen Z; Zhang T; Wei P; Liang H; He Y; Zheng C; Wang X; Zhang Y
Oncol Lett; 2024 May; 27(5):232. PubMed ID: 38586210
[TBL] [Abstract][Full Text] [Related]
6. Suicide gene strategies applied in ovarian cancer studies.
Nguyen QM; Dupré PF; Haute T; Montier T; d'Arbonneau F
Cancer Gene Ther; 2023 Jun; 30(6):812-821. PubMed ID: 36717737
[TBL] [Abstract][Full Text] [Related]
7. Understanding and addressing barriers to successful adenovirus-based virotherapy for ovarian cancer.
Gonzalez-Pastor R; Goedegebuure PS; Curiel DT
Cancer Gene Ther; 2021 May; 28(5):375-389. PubMed ID: 32951021
[TBL] [Abstract][Full Text] [Related]
8. Combination of a MDR1-targeted replicative adenovirus and chemotherapy for the therapy of pretreated ovarian cancer.
Rein DT; Volkmer A; Bauerschmitz G; Beyer IM; Janni W; Fleisch MC; Welter AK; Bauerschlag D; Schöndorf T; Breidenbach M
J Cancer Res Clin Oncol; 2012 Apr; 138(4):603-10. PubMed ID: 22209976
[TBL] [Abstract][Full Text] [Related]
9. Bugs and drugs: oncolytic virotherapy in combination with chemotherapy.
Wennier ST; Liu J; McFadden G
Curr Pharm Biotechnol; 2012 Jul; 13(9):1817-33. PubMed ID: 21740354
[TBL] [Abstract][Full Text] [Related]
10. Targeted cytosine deaminase-uracil phosphoribosyl transferase suicide gene therapy induces small cell lung cancer-specific cytotoxicity and tumor growth delay.
Christensen CL; Gjetting T; Poulsen TT; Cramer F; Roth JA; Poulsen HS
Clin Cancer Res; 2010 Apr; 16(8):2308-19. PubMed ID: 20371678
[TBL] [Abstract][Full Text] [Related]
11. [Killing effect of adenovirus mediated fusion gene cytosine and deaminase uracil phosphoribosyl transferase directed by glutathione S-transferase P1 promoter on cisplatin-resistant ovarian cancer cells in vitro].
Cai LQ; Li M; Lu S; Wang HB; Wang ZH
Zhonghua Fu Chan Ke Za Zhi; 2004 Jul; 39(7):478-81. PubMed ID: 15347473
[TBL] [Abstract][Full Text] [Related]
12. Reversal of multi-drug resistance by vector-based-shRNA-mdr1 in vitro and in vivo.
Lu S; Huang Q; Wang Z; Song Y; Wang L
J Huazhong Univ Sci Technolog Med Sci; 2009 Oct; 29(5):620-4. PubMed ID: 19821097
[TBL] [Abstract][Full Text] [Related]
13. [Reverse of the resistance to paclitaxel of the heparin binding-epidermal growth factor-like growth factor inhibitor in ovarian cancer].
Tang XH; Lu MS; Deng S; Li M
Zhonghua Fu Chan Ke Za Zhi; 2017 Feb; 52(2):110-115. PubMed ID: 28253574
[No Abstract] [Full Text] [Related]
14. Mechanistic analysis of taxol-induced multidrug resistance in an ovarian cancer cell line.
Wang NN; Zhao LJ; Wu LN; He MF; Qu JW; Zhao YB; Zhao WZ; Li JS; Wang JH
Asian Pac J Cancer Prev; 2013; 14(9):4983-8. PubMed ID: 24175763
[TBL] [Abstract][Full Text] [Related]
15. Gene therapy for ovarian cancer using adenovirus-mediated transfer of cytosine deaminase gene and uracil phosphoribosyltransferase gene directed by MDR1 promoter.
Lu S; Wang X; Xiao L; Cai L; Zhang Y; Wang H; Wang Z
Cancer Biol Ther; 2007 Mar; 6(3):397-404. PubMed ID: 17471022
[TBL] [Abstract][Full Text] [Related]
16. Gene therapy of adenovirus mediated CD ::upp/5-FC directed by GSTP1 promoter in cisplatin-resistant ovarian cancer.
Wang Z; Cai L; Wang H
Gynecol Oncol; 2005 Mar; 96(3):643-50. PubMed ID: 15721406
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
